Novartis AG

Schedule 13G - Passive Investments

NYSE

17 Jul 2025

NVS

SCHEDULE: UBS Group AG Discloses 6.37% Stake in Novartis AG with Significant Filing Delay

UBS Group AG, through its Asset Management division, has disclosed a 6.37% beneficial ownership stake in Novartis AG as of September 30, 2024, with the filing delayed due to system integration issues.

Delay expected

Worse than expected